Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

PREPARE

5. Vaccines & Therapeutics

Meet our Vaccines & Therapeutics team

Last updated on 16 October 2026

The Vaccines and Therapeutics Co-operative led by Professor Sylvie Alonso aims to develop broadly protective vaccines and therapeutics within specific pandemic viral families, or pathogen-agnostic technologies and platforms to enhance Singapore’s pandemic resilience and readiness.

Key personnel

Lead

Image of Professor Sylvie Alonso

Professor Sylvie Alonso leads the PREPARE Vaccines & Therapeutics Co-operative. She is a tenured Professor at the National University of Singapore (NUS) Department of Microbiology and Immunology, Co-Chair of the Infectious Diseases Translational Research Programme (IDTRP) at NUS Yong Loo Lin School of Medicine, and Deputy Director of Life Sciences Institute at NUS.

Deputy Lead

Image of Conrad Chan

Dr Conrad Chan is the Deputy Lead of the Vaccines & Therapeutics Co-operative. He is also the Lead of the Laboratory Research Core, and a Senior Principal Scientific Officer (PREPARE Laboratory) in CDA with a background in virology and immunology. He did his PhD in Immunology at National University of Singapore on the development of therapeutic monoclonal antibodies against viral pathogens. His research interests are in high containment laboratories, humoral immunity and serology, vaccine and therapeutic testing/evaluation and viral characterization and biobanking.

Senior Manager

Describe what the image is about.

Dr Neha Dikshit is Senior Manager at PREPARE. With a PhD in immunology, she is involved in the development and management of strategic research initiatives within the Vaccines & Therapeutics Co-operative to strengthen national pandemic preparedness capabilities.

Mission

To strengthen Singapore's pandemic preparedness through integrated research, translational development, and strategic foresight in vaccines and therapeutics.

Objectives

  1. Build and sustain local pandemic and outbreak research expertise and capabilities

  2. Establish a pre-clinical research pipeline for the development of pandemic vaccine and therapeutic candidates

  3. Facilitate clinical translation and product development of promising candidates

  4. Horizon mapping of vaccine platforms & technologies relevant to pandemic preparedness

  5. Inform national pandemic preparedness policies and strategies

Strategy

  1. Targeted funding through open grant calls and commissioned studies to support pandemic pre-clinical research and infrastructure

  2. Collaborations and partnerships across academia, industry and international networks to co-develop promising pandemic relevant V&T candidates

  3. Roadmaps for clinical development including TPP development and clinical evaluation of promising V&T candidates

  4. Strategic evidence to inform national pandemic preparedness policies, including assessments of priority pathogens, vaccine platforms, and emerging technologies


V&T pipeline
V&T portfolio